| 王艺霖,徐晓娟,陈雁.聚腺苷二磷酸核糖聚合酶抑制剂(PARPi)治疗卵巢癌:影像学研究进展[J].中国医学影像技术,2023,39(4):618~621 |
| 聚腺苷二磷酸核糖聚合酶抑制剂(PARPi)治疗卵巢癌:影像学研究进展 |
| Treating ovarian cancer with poly adenosine diphosphate ribosepolymerase inhibitor (PARPi): Progresses of imaging |
| 投稿时间：2022-09-27 修订日期：2022-12-12 |
| DOI：10.13929/j.issn.1003-3289.2023.04.030 |
| 中文关键词: 卵巢肿瘤 聚腺苷二磷酸核糖聚合酶抑制剂 诊断显像 |
| 英文关键词:ovarian neoplasms poly adenosine diphosphate ribosepolymerase inhibitor diagnostic imaging |
| 基金项目: |
|
| 摘要点击次数: 1004 |
| 全文下载次数: 824 |
| 中文摘要: |
| 聚腺苷二磷酸核糖聚合酶抑制剂(PARPi)的出现,开启了维持治疗卵巢癌的新篇章,使大部分患者预后得到明显改善。影像学可对患者进行非侵入性全面评估,为临床诊治提供重要信息。本文就PARPi作用原理及影像学有关PARPi治疗卵巢癌进展进行综述。 |
| 英文摘要: |
| The emergence of poly adenosine diphosphate ribosepolymerase inhibitor (PARPi) opened up a new chapter for maintenance treatment of ovarian cancer. The application of PARPi significantly improved the prognosis of most patients. Imaging can provide non-invasive, comprehensive assessment of patients, hence providing important information for clinical diagnosis and treatment. The principle of action of PARPi and imaging processes relative to treatment of ovarian cancer with PARPi were reviewed in this article. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
